[Bronchial asthma: progress in diagnosis and treatments. Topics: II. Pathogenesis and pathophysiology; 1. The Dutch hypothesis and British hypothesis].

[1]  C. Salome,et al.  Prevalence and nature of bronchial hyperresponsiveness in subjects with chronic obstructive pulmonary disease. , 2015, The American review of respiratory disease.

[2]  M. Lebowitz,et al.  Epidemiologic observations on eosinophilia and its relation to respiratory disorders. , 2015, The American review of respiratory disease.

[3]  P. O'Byrne,et al.  Sputum inflammatory cells and allergen‐induced airway responses in allergic asthmatic subjects , 2011, Allergy.

[4]  H. Young,et al.  Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. , 2007, American journal of respiratory and critical care medicine.

[5]  R. Homer,et al.  State of the art. Mechanistic heterogeneity in chronic obstructive pulmonary disease: insights from transgenic mice. , 2006, Proceedings of the American Thoracic Society.

[6]  J. Elias.  The relationship between asthma and COPD. Lessons from transgenic mice. , 2004, Chest.

[7]  Stefano Guerra,et al.  Asthma as a risk factor for COPD in a longitudinal study. , 2004, Chest.

[8]  J. Connett,et al.  Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. , 2000, The New England journal of medicine.

[9]  A. Woolcock,et al.  Lung function growth and its relation to airway hyperresponsiveness and recent wheeze. Results from a longitudinal population study. , 2000, American journal of respiratory and critical care medicine.

[10]  S. Spencer,et al.  Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial , 2000, BMJ : British Medical Journal.

[11]  E. Melillo,et al.  Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. , 1999, American journal of respiratory and critical care medicine.

[12]  D. Postma,et al.  Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking , 1999 .

[13]  P. Lange,et al.  Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial , 1999, The Lancet.

[14]  Scott T Weiss,et al.  Airways responsiveness and development and remission of chronic respiratory symptoms in adults , 1997, The Lancet.

[15]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[16]  Phil A. Silva,et al.  The effects of airway hyperresponsiveness, wheezing, and atopy on longitudinal pulmonary function in children: A 6‐year follow‐up study , 1992, Pediatric pulmonology.

[17]  R. Taylor,et al.  Smoking, allergy, and the differential white blood cell count. , 1985, Thorax.

[18]  R. Roberts,et al.  Bronchial responsiveness to methacholine in chronic bronchitis: relationship to airflow obstruction and cold air responsiveness. , 1984, Thorax.

[19]  L. Reid.  THE ROLE OF CHRONIC BRONCHITIS IN THE PRODUCTION OF "CHRONIC OBSTRUCTIVE PULMONARY EMPHYSEMA". , 1965, Journal of the American Medical Women's Association.

[20]  P. Jeffery.  Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. , 2004, Proceedings of the American Thoracic Society.